Skip to main content
Veterinary Medicines

Boflox flavour, 80mg, oral tablet for dogs

Authorised
  • Marbofloxacin

Product identification

Medicine name:
Boflox flavour, 80mg, oral tablet for dogs
Boflox flavour 80 mg Tabletten für Hunde
Active substance:
  • Marbofloxacin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Marbofloxacin
    80.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • box containing 240 tablets (40 blister)
  • box containing 120 tablets (20 blister)
  • box containing 72 tablets (12 blister)
  • box containing 36 tablets (6 blister)
  • box containing 12 tablets (2 blister)
  • box containing 6 tablets (1 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402293.00.00
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0330/002
Concerned member states:
  • Austria
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
German (PDF)
Published on: 19/12/2024

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download
German (PDF)
Published on: 19/12/2024

Labelling

English (PDF)
Published on: 22/12/2023
Download

eu-PUAR-esv0330002-dcp-boflox-flavour--80mg--oral-tablet-for-dogs-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."